Prevalent genetic alterations in pediatric thyroid carcinoma: Insights from an Argentinean study
PLOS One · 2025
DOI: 10.1371/journal.pone.0323271 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Sandra Lorena Colli und 9 weiteren Autor:innen. Beteiligte Einrichtung: División Patología, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Instituto Nacional del Cáncer, Fundación H.A. Barceló.
Abstract (Originalsprache)
Thyroid cancer is the primary endocrine malignancy, exhibiting distinct genomic drivers. The frequency of genetic alterations varies between adult and pediatric groups and across geographic regions and ethnicities. Molecular markers may serve as prognostic tools and/or specific treatment-selection tools in papillary thyroid carcinoma (PTC) in children. We sought to characterize molecular alterations in pediatric PTC from Argentina and test a future laboratory algorithm for molecular diagnosis and stratification. Immunohistochemistry, fluorescence in situ hybridization, and Sanger sequencing were performed on 57 pediatric PTC samples. This study assesses multiple genetic alterations, including fusions in RET, ALK, MET, BRAF, and NTRK genes, as well as the BRAF V600E single nucleotide variant. Fusions in known oncogenes were observed in 29.8% of cases (6 in RET, 5 in ALK, 4 in NTRK3, 1 in BRAF, and 1 in MET). The BRAF V600E SNV was detected in 12.3% of cases. Larger tumor size and higher initial risk were associated with genetic alterations ( P = 0.027 and P = 0. 036, respectively). Designing a laboratory algorithm following an increasing order of complexity provided a reliable molecular testing platform that reduces the requirement for NGS screening. These results also broaden the data on PTC alterations in children from Argentina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- División Patología, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina.
- Laboratorio de Biología Molecular, División Patología, Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas (IMIPP), CONICET-GCBA, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina.
- División de Endocrinología, Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE), CONICET-FEI-GCBA, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina.
- Unidad de Oncología, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina.
ORCID-Profile: María Victoria Preciado
Förderung
- Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
- Instituto Nacional del Cáncer
- Fundación H.A. Barceló
Zitieren
APA
Colli, S. L., Boycho, M. E., Papendieck, P., Mangone, F. M., Chiesa, A., García Lombardi, M., Medín, M., De Matteo, E. N., Lorenzetti, M. A., & Preciado, M. V. (2025). Prevalent genetic alterations in pediatric thyroid carcinoma: Insights from an Argentinean study. PLOS One. https://doi.org/10.1371/journal.pone.0323271
Vancouver
Colli SL, Boycho ME, Papendieck P, Mangone FM, Chiesa A, García Lombardi M, et al. Prevalent genetic alterations in pediatric thyroid carcinoma: Insights from an Argentinean study. PLOS One. 2025. doi:10.1371/journal.pone.0323271
BibTeX
@article{Colli2025,
author = {Colli, Sandra Lorena and Boycho, Marisa Esther and Papendieck, Patricia and Mangone, Franco Mauricio and Chiesa, Ana and García Lombardi, Mercedes and Medín, Martín and De Matteo, Elena Noemí and Lorenzetti, Mario Alejandro and Preciado, María Victoria},
title = {Prevalent genetic alterations in pediatric thyroid carcinoma: Insights from an Argentinean study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0323271}
}
EUVIMED